22nd Century Group, Inc. (XXII) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2025. 22nd Century Group, Inc. is a tobacco products company focused on reduced nicotine content (RNC) products, including its flagship FDA-authorized Modified Risk Tobacco Product (MRTP), VLN®. The company operates as a single reportable segment and is currently classified as a non-accelerated filer and smaller reporting company. As of August 11, 2025, there were 3,670,426 shares of common stock issued and outstanding.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Revenue | $4.1 million | $7.9 million | $10.0 million | $14.4 million |
| Gross Profit (Loss) | ($0.6 million) | $0.6 million | ($1.2 million) | ($0.6 million) |
| Operating Loss | ($3.0 million) | ($2.0 million) | ($5.6 million) | ($6.5 million) |
| Net Loss (Continuing Ops) | ($3.3 million) | ($2.2 million) | ($6.6 million) | ($7.7 million) |
| Net Loss (Total) | ($3.4 million) | ($1.1 million) | ($7.7 million) | ($6.9 million) |
| Cash & Equivalents | $3.1 million (as of June 30, 2025) | |||
| Working Capital | ($3.1 million) deficit (as of June 30, 2025) | |||
| Total Debt (Current) | $3.9 million (Senior Secured Credit Facility) |
Material Changes vs. Prior Period
- Revenue Decline: Q2 2025 revenue decreased 48.6% year-over-year to $4.1 million. This was driven by a shift in product mix, lower volumes in filtered cigars, and the absence of a one-time $0.9 million research cigarette order in the prior year. Despite the revenue drop, total cartons sold increased slightly (779 vs. 719).
- Gross Margin Deterioration: The company reported a gross loss of $0.6 million in Q2 2025, compared to a gross profit of $0.6 million in Q2 2024. Gross margin turned negative (-15.6%) due to volume decreases and product mix shifts.
- Expense Reduction: Operating expenses decreased 10.4% to $2.3 million, primarily due to lower headcount, reduced insurance premiums, and lower legal costs, partially offset by increased strategic consulting fees.
- Discontinued Operations: The company divested its hemp/cannabis business. Q2 2025 included a loss of $0.1 million from discontinued operations, compared to income of $1.1 million in the prior year period.
- Debt Restructuring: The Senior Secured Credit Facility balance was reduced via debt conversions and mandatory prepayments. In Q1 2025, $3.1 million of debt was converted to equity. In Q2 2025, $1.0 million was repaid using proceeds from a warrant inducement.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management has expressed substantial doubt about the company's ability to continue as a going concern for one year following the report date. This is due to significant accumulated deficits ($401.6 million), negative operating cash flows, and a working capital deficit.
- Liquidity Strategy: The company is pursuing financing strategies including equity issuance, debt issuance, and asset sales. In April 2025, the company raised $5.1 million through a warrant inducement exercise.
- Product Launches: Management anticipates the launch of rebranded VLN® products and partner products in the third quarter of 2025.
- Legal Contingencies:
- Insurance Litigation: A trial is scheduled for November 4, 2025, regarding a business interruption claim against Dorchester Insurance following a 2022 fire at the Grass Valley facility.
- Shareholder Derivative: A settlement was approved in July 2025 for $0.8 million in legal fees, fully covered by insurance.
- Other Disputes: Ongoing litigation includes disputes with Keygene (resolved April 2025), Cookies Retail Products, and a former employee regarding the 2022 fire.
- Debt Covenants: The company is currently in compliance with financial covenants related to its Senior Secured Credit Facility, though the facility matures in March 2026.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $3.1 million cash balance against projected operating burn rates and mandatory debt service payments.
- Debt Maturity: Confirm the status of the $3.8 million Senior Secured Credit Facility maturing in March 2026 and the feasibility of refinancing or conversion.
- Revenue Quality: Assess the sustainability of contract manufacturing revenue, noting the concentration risk (Customer A represented 48.7% of Q2 revenue).
- Insurance Recovery: Monitor the outcome of the November 2025 trial regarding the business interruption claim, which could impact liquidity.
- Warrant Dilution: Review the impact of outstanding warrants (approx. 4.5 million) with anti-dilution provisions and "zero exercise price" features on future equity value.